Back
To Oral Chelation Center
Double Blind
Studies have shown significant decreases in
degenerative liver damage in patients with chronic liver disease(Cirrhosis of the Liver) while using
Extreme Health's Liver Support Formula in as few as 30-90
days.
$24.95
90 caps
 $24.95
2CheckOut.com Inc. (Ohio, USA) is an authorized retailer for
goods and services provided by Women's Health-Natural Solutions.com.
Check Out
Recommended for those who:
- Have a history of a Fatty Liver
- Consume Alcohol
- Consume Tobacco Products
- Have been taking Medications/Drugs
- Are exposed to Environmental Toxins or Chemicals or Second Hand Smoke
- Have a history of Liver or Gall Bladder Problems
Liver Support
Formula
(artichoke-liver-detox)
This is an extremely effective product
for detoxifying the liver normalizing liver metabolism and preventing further
liver damage.
The accumulation of chemicals in our
body from the water that we drink, and bathe in the air that we breathe, and the
food that we eat have been shown to weaken the immune system and contribute to
the development degenerative diseases like cancer.
Liver Support System
Ingredient Rationale
A proprietary blend of artichoke
(Cynara Floridanum) and sarsaparilla (Smilax Aristolochiaefolia) that contains
the following naturally occurring bioflavonoids and polyphenols: silymarin,
quercetin, catechin, hesperidin, rutin, cynarin and chlorogenic acid.
Bioflavonoids are a class of water-soluble plant pigments (colors) that have
anti-inflammatory antihistaminic and anti-viral properties. Health professionals
formulated The Liver Support System specifically for detoxifying the liver and
gall bladder and supporting each of their functions.
Included
Bioflavonoids
1. Silymarin
Numerous
clinical studies have shown silymarin to be among the most powerful natural
agents available for the prevention and treatment of liver damage caused by
exposure to human-made chemicals including alcohol induced liver degeneration
and cirrhosis.
2. Quercetin
Quercetin is a
bioflavonoid with antioxidant effects. It is used for the prevention of
atherosclerosis hypercholesterolemia (excess cholesterol in the blood) and
coronary heart disease. It can inhibit carcinogenesis and reduce capillary
fragility. Quercetin is used extensively in the treatment of athletic injuries,
because it relieves pain and bruising and acts synergistically with Vitamin C to
protect and preserve the structure of capillaries. It also promotes circulation
lowers cholesterol levels and treats and prevents cataracts. Quercetin fights
cancer, diabetes, capillary fragility and arthritis; stabilizes membranes;
protects against heart disease and allergies; normalizes blood pressure; helps
lowers cholesterol; and slows aging.
3. Catechin
Catechin,
another naturally occurring flavonoid, is similar in effect to silymarin.
Catechin is a powerful anti-oxidant that helps prevent free radical oxidative
damage to cells. It also helps in the treatment and prevention of alcohol and
chemical-induced liver disease or damage. Catechin is also valuable for its
ability to neutralize intestinal toxins and assist in the stabilization of cell
membranes.
4. Hesperidin
Hesperidin has been shown to
be useful in clinical trials as an analgesic and anti-inflammatory.
5. Rutin
An antioxidant
bioflavonoid, free radical scavenger, and an iron-chelator. It is used as a
vascular protector for reducing capillary fragility, permeability and bleeding;
as a treatment for varicose vein symptoms; and as preventive for stroke (the
sudden rupture or clotting/blockage of a blood vessel to the brain). Some
studies show that Rutin offers protection from damage induced by asbestos, the
cytotoxic effects of oxidized low-density lipoproteins (LDL), and gastric injury
from ethanol. It also offers some protection against DNA damage caused by
hepatocarcinogens. Rutin is used extensively in the treatment of athletic
injuries because it relieves pain and bruises and acts synergistically with
Vitamin C to protect and preserve the structure of capillaries. It also promotes
circulation, lowers cholesterol levels, and treats and prevents
cataracts.
6. Cynarin
Cynarin assists
in the detoxification of the liver and gall bladder. It also supports the
function of these two important organs while and assists in their regeneration
following damage. Cynarin stimulates the clearance of bile from the liver,
preventing congestion in the liver and thus diminishing the chances of liver
damage.
7. Sarsaparilla
Sarsaparilla
has been used in the treatment of the following conditions: gout, arthritis,
digestive disorders, skin diseases and cancer. Sarsaparilla contains saponins,
which are steroid-like agents that bind with toxins in the digestive tract.
Historically sarsaparilla has been used as a 'blood purifier' and a general
tonic for diseases associated with increased endotoxin levels, including
arthritis, intestinal ulcerative conditions, eczema and
psoriasis.
The tonic effect of sarsaparilla is
the result of its ability to stimulate the removal of accumulated waste products
from the cells, blood and lymph. These actions tend to increase the health of
the entire body and increase vitality, thereby increasing energy and
endurance.
8. Chlorogenic Acid
(16%)
Chlorogenic Acid is a naturally occurring, water soluble, phenolic
acid that is a potent anti-oxidant, carcinogenic inhibitor and protector against
lipid peroxidation and free radical mediated cell injury. $24.95
90 Caps
$24.95
2CheckOut.com Inc. (Ohio, USA) is an authorized retailer for
goods and services provided by Women's Health-Natural Solutions.com.
Check Out
DOUBLE BLIND STUDY
2nd Double Blind
Study
COMPARATIVE STUDY BETWEEN A
COMPLEX OF FLAVONOIDS AND POLYPHENOLS CREATED FROM EXTRACTS OF ARTICHOKE AND
SARSAPRILLA AND A PLACEBO IN ALCOHOL RELATED LIVER DISEASE
DECEMBER
12 1998
In a previous study completed over two
years ago in this same hospital an extract of artichoke (Cynara Floridanum) and
sarsaparilla (Smilax Aristolochiaefolia) was evaluated in addressing the
symptoms related to alcoholic liver disease. This study was accomplished over a
fifteen-day period with exceptional results. Because of these results noted over
a very short period of time, the hospital researchers were anxious to set up the
same study over a longer period (30 days). Please refer to the July 3, 1996,
study for descriptions of symptoms and study parameters. Results of this study
are as follows:
ASCITES
A 72.38%
reduction of the accumulation of serous abdominal fluid was noted in the treated
group. The placebo saw a 6.35% increase in abdominal fluid.
ENCEPHALOPATHY
A
66.08% reduction of symptoms related to encephalopathy was noted in the treated
group. The placebo group saw a 12.24% increase in these symptoms.
HEPATOMEGALY
The
treated group experienced a 93.33% reduction in enlarged livers. In the placebo
group their livers continued to enlarge by another 7.14%.
SPLENOMEGALY
An 88.40%
reduction in spleen enlargement was noted with the treated group. The placebo
group worsened by 11.54%.
WEAKNESS
The
treated group noted a 73.64% increase in strength. There was a decrease in
muscle strength by 7.41% in the placebo group.
PERIPHERAL
EDEMA
Edema in the extremities of the treated patients decreased by
48.21%. There was no change in the placebo group.
HEMORRHAGES
The
treated group noted a 100% decrease in capillary hemorrhaging in the skin gums
and nasal membranes. The placebo group saw an increase of 28.57% in
hemorrhaging.
ANOREXIA
Loss of
appetite decreased in the treated group by 76.98%. The placebo group noted a
decrease of 3.70%.
ABDOMINAL WALL
VEINS
The treated group experienced a 60.62% decrease in tortuous
veins in the abdomen related to ascites. The placebo group saw a 3.33%
decrease.
PALMAR
ERYTHEMA
The treated group noted a 26.67% decrease in red and
swollen palms. In the placebo group there was no change.
TELANGIECTASIA
A
60.00% reduction in vascular lesions was noted in the treated group. A 3.33%
reduction was seen in the placebo group.
TOTAL
BILIRUBIN
The treated group noted a reduction of total bilirubin by
38.95%. The placebo group increased by 5.68%.
ALKALINE
PHOSPHATASE
The treated group obtained 25.91% reduction in alkaline
phosphates. There was an 11.69% increase in the placebo group.
SERUM GLUTAMIC OXALCETIC
TRANSAMINASE (SGOT)
The treated group noted a decrease of 23.83% in
SGOT levels. The placebo group experienced a worsening of 11.71%.
PROTHROMBIN TIME
A
42.00% reduction in clotting time was noted with the treated group. An increase
in clotting time was noted in the placebo group of 6.60%.
SERUM ALBUMIN
An
increase of 37.27% in serum albumin was noted in the treated group. There was a
decrease in the placebo group of 1.95%.
GAMMA GLUTAMYL TRANSPEPTIDASE
(GGT)
The treated group noted a reduction of 23.79% in GGT. The
placebo group experienced an increase of 9.92%.
DR. CHARLES
COCHRAN
1st Double
Blind Study
INTERPRETATION OF RESULTS OBTAINED IN A
DOUBLE BLIND TEST MADE IN THE GENERAL HOSPITAL MEXICO WITH THE PRODUCT LIVER
SUPPORT ON PATIENTS HAVING CHRONIC ALCOHOLIC HEPATIC DISEASE.
In order to analyze carefully the
results of this study, it is necessary to know the importance of the two
clinical and laboratory parameters intervening in the calculations of Orrego and
Maddrey Indexes. We will compare the results of the parameters, the placebo
control and the Liver Support groups on both indexes. The results are presented
as percentages of recovery and are obtained from the data obtained from each
group of 30 patients; we will get an average of those results at the beginning
and at the end of the study. Both averages will give us a final recovery
compared to the initial values. This way we may demonstrate the effectiveness of
Liver Support.
DEFINTIONS AND RESULTS OF
PARAMETERS
ASCITES- Effusion and
accumulation of serous fluid in the abdominal cavity. The experimental group
(Liver Support) experienced a 28.8% reduction of ascites while the placebo group
experienced no change.
ENCEPHALOPATHY- a DEGENERATIVE
DISEASE OF THE BRAIN. Hepatic encephalopathy- a condition usually occurring
secondarily to advanced disease of the liver. It is marked by disturbances of
consciousness that may progress to deep coma (hepatic coma) psychiatric changes
of varying degree, flapping tremor and fetor hepaticas. Also called
portal-systemic encephalopathy. Patients on Liver Support experienced a 34.55%
reduction of hepatic encephalopathy. The placebo group experienced a 5.5%
reduction.
SPLENOMEGALIA- Enlargement of
the spleen. An 18.18% reduction was observed in the Liver Support group and a
55% reduction was observed in the placebo group.
WEAKNESS- Lacking physical
strength or vigor marked by asthenia atony cardiasthena enervation fatigue and
lassitude. The Liver Support group experienced an 83.45% decrease in the
incidence of weakness while the placebo group reported no change.
PERIPHERAL EDEMA- A condition
in which the body tissues contain an excess amount of fluid. The Liver Support
Group experienced an 11.10% reduction in peripheral edema while the placebo
group had a 0.69% reduction.
HEMORRHAGES- Bleeding. This was
one of the most important benefits observed in the Liver Support group. The
Liver Support group had an 89.41% reduction in hemorrhages while the placebo had
a 31% reduction.
ANOREXIA- Loss of appetite.
Seen in depression malaise commencement of fevers and illness also in disorders
of the alimentary tract especially of the stomach and as a result of alcoholic
excess and drug addiction. Anorexia was diminished by 86.07% in the Liver
Support group. There was no change in the placebo group.
TOTAL BILIRUBIN LEVEL - The
predominant pigment of human bile. Total serum bilirubin may be increased in
cirrhosis of the liver and acute viral hepatitis. The Liver Support group
obtained 25.11% reduction in bilirubin whereas the placebo group had a 7.2%
increase.
OGT - (Oxalacetic Glutamic
Transaminase). It is distributed all over body tissue especially in the heart
and liver. Less amounts are found in the spleen pancreas kidneys lungs and
brain. Any lesion of a tissue leads to the secretion of this enzyme to the blood
stream. The activity of OGT is risen under hepatic necrosis cirrhosis of the
liver or hepatic metastasis. In those patients who received Liver Support this
level diminished 22.56% in only 15 days of treatment and in the placebo group it
diminished 8.51%.
PROTHROMBINE TIME - A test of
clotting time made by determining the time for clotting to occur after
thromboplastin and calcium are added to decalcified plasma. There was 30.82%
reduction in prothrombin time for Liver Support patients whereas the placebo
group's time increased 1.25%. This is very important data because it means that
Liver Support helps the healing of wounds faster.
SERUM ALBUMIN - One of a group
of simple proteins widely distributed in tissues. Albumin is a constituent of
blood. Low levels of albumin in blood plasma are associated with a pathologic
condition of the liver. The Liver Support group experienced an increase of 8.85%
of total albumin levels while the placebo group experienced a 5.35%
increase.
Article published about Extreme's Liver Support
Formula in:
"THE TOWNSEND LETTER for DOCTOR'S
PATIENTS"
HEPATITIS LIVER
CIRRHOSIS/HCC
Increasing Evidence Suggest Extreme Health's Liver Support
Formula may be Effective in Compromising the Detrimental Effects of
Hepatitis-Engendered Cirrhosis.
AUTISM AND DETOXIFICATION
Might autistic children be the
proverbial "canaries in the coal mine" whose nervous systems are more
susceptible to the impact of toxic heavy metals in the environment incurring
neurological damage even at low exposure levels? One recent study found that in
one group of 18 autistic children 16 had blood levels of toxic heavy metals and
chemicals exceeding adult maximum tolerance. This build-up of toxins may not
arise simply from excessive exposure but from a marked inability to process and
eliminate toxins from the body. Indeed when the children were assessed using a
biochemical analysis to gauge the body's ability to detoxify substances
researchers found that every child showed out-of-range results suggesting a
defect in this two-phase detoxification process. (Reason Extreme Health's
Liver Support Formula is important.) Researchers explained that such a mechanism
could lead to a backup of toxic heavy metals and chemical toxins with increased
free radical activity in the body. Since the blood-brain barrier of children is
still not fully developed these toxic and oxidized molecules could penetrate
into regions of the brain and damage neutrons receptors synapses enzymes and
cell mitochondria and also set off auto immune reactions triggering further
damage.
According to other studies autistic
children may have problems metabolizing and detoxifying certain compounds due
to an impaired biochemical process called sulfation. Sulfation plays an
important role in the second phase of the detoxification process. (Reason
Extreme Health's Liver Support Formula is important.) Impaired sulfation could
make autistic children more vulnerable to multiple heavy metal and chemical
sensitivities. It may also help explain an exacerbation of behavioral problems
after children eat foods containing phenol tyramine and phenyl compounds which
are normally neutralized through the sulfation process.
Much concern has been raised over the
link between exposure to heavy metal toxins and neurological brain damage
associated with learning and behavior disorders in children. Indeed research
shows that exposure to heavy metals such as lead mercury and antimony can impair
brain development at very early ages even at low doses previously deemed
"harmless." Children are particularly susceptible to the deleterious effects of
heavy metal exposure for several reasons. First their developing nervous
systems are more sensitive. Second their bodies absorb toxins more rapidly yet
clear them from the system more slowly than from adults.(Reason Extreme
Health's Liver Support Formula is important.) Finally a child's blood-brain
barrier the natural protective mechanism which blocks harmful substances from
entering and damaging the brain is not yet fully formed.
Many professionals working in the
field of autism have expressed concern that some autistic children were exposed
to potentially damaging levels of ethylmercury which is a preservative used in
certain vaccinations. Clinical neurobehavioral symptoms of mercury poisoning
seem to parallel closely many common symptoms of autism. In response to pressure
from the FDA the U.S. Public Health Service and other regulatory health agencies
vaccine manufacturers have since worked to reduce or eliminate the use of
ethylmercury as a preservative in many vaccines.
In addition several studies have
associated high lead levels in children with autism. Elevated levels of lead in
hair - signify long-term toxic exposure to this heavy metal - were correlated
with increased behavior abnormalities and learning disorders in children.
Based on clinicians' observations antimony a potential toxin found in some
fire retardant materials is also a possible cause for concern.
Nutritional balance and healthy
metabolism are also very important. Dr. Lynn Wecker and his colleagues at
Louisiana State Medical Centre observe that trace element imbalances in the
human body can disrupt neurotransmitter function and produce marked changes in
behavior; many of which are consistent with symptoms of autism. For this reason
Dr. Wecker and his team evaluated trace element concentrations in the hair of
autistic children. They found clear deficiencies of calcium, copper, zinc, and
chromium that were so striking that they allowed them to discriminate between
autistic children and healthy controls with a high degree of accuracy using just
test results. Deficiencies of mineral nutrients can make a child more
susceptible to heavy metal absorption. Magnesium deficiencies associated with
attention-deficit disorder and hyperactivity may also be clinically significant
in autism. Extreme Health's Liver Support Formula radically improves
liver metabolism and promotes the detoxification of the liver and the body.
Review
Liver Support Ingredients
More Liver Artices
$24.95 90 Caps
2CheckOut.com Inc. (Ohio, USA) is an authorized retailer for
goods and services provided by Women's Health-Natural Solutions.com.
Check Out
REFERENCES:
Accardo P Whitman B Caul J Rolfe U. Autism and
plumbism. A possible association. Clinical Pediatric 1988; 27(1):41-4.
Alberti A Pirrone P Elia M Waring RH Romano C.
Sulphation deficit in "low-functioning" autistic children: a pilot study. Biol
Psychiatry 1999;46(3):420-4.
Cohen DJ Johnson WT Caparulo BK. Pica and elevated
blood lead level in autistic and atypical children. Am J Dis Child
1976;130(1):47-48.
Edelson SB Cantor DS. Autism: Xenobiotic influences.
Toxicology and industrial health 1998;14(4):553-563.
Emory E Pattillo D Archibald E Byroh M Sung F.
Neurobehavioral effects of low-level lead exposure in human neonates. Am J
Obstet Gynecol 1999;181:S2-S11.
Eufemia P Celli M Finocchiaro R Pacifico L Viozzi L
Zaccagnini M Cardi E Giardini O. Abnormal intestinal permeability in children
with autism. Acta Paediatr 1996:85(9):1076-9.
Goodwin MS Cowen MA Goodwin TC. Malabsorption and
cerebral dysfunction: a multivariate and comparative study of autistic children.
J Autism Child Schizophr 1971; 1:48-62.
Halsey NA. Limiting infant exposure to thimerosal in
vaccines and other sources of mercury. JAMA. 199 Nov 10;282(18):1763-6.
Horvath K Papadimitriou JC Rabsztyn A Drachenberg C
Tildon JT. Gastrointestinal abnormalities in children with autistic disorder. J.
Pediatr 1999; 135:559-63.
Kozielec T Starobrat-Hermelin B. Assessment of
magnesium levels in children with attention deficit hyperactivity disorder
(ADHD). Magnes Res; 1997 Jun; 10(2):143-8.
Lanphear BP Dietrich K Auinger P Cox C. Subclinical
lead toxicity in U.S. children and adolescents [abstract#894]. APS/SPR Joint
Meeting; 2000 May 12-16;
Boston MA. McFadden SA. Phenotypic variation in
xenobiotic metabolism and adverse environmental response: focus on
sulfur-dependent detoxification pathways. Toxicology 1996;111 (1-3):43-65.
Shannon M Graef Jw. Lead intoxication in children
with pervasive developmental disorders. J Toxicol Clin Toxicol
1996;34(2):177-81.
Tuthill RW. Hair lead levels related to children's
classroom attention-deficit behavior. Arch Enciron Health 1996;(3):214-220.
Wecker L Miller SB Cochran SR Dugger DL Johnson WD.
Trace element concentrations in hair from autistic children. J Ment Defic Res
1985; 15-22.Wilson MA Johnston MV Goldstein GW Blue ME. Neonatal
lead exposure impairs development of rodent barrel field cortex. PNAS 2000;
97(10):5540-5545.
|
The information on this site is not required or has not been evaluated by the Food and Drug Administration.
These products
are
not intended to treat, diagnose, cure, or prevent any disease. Please consult your doctor before you go on a new holistic health program.
Find a Holistic Physician Here |
Need Help?
To
Mail-Phone Your Order ....Click
here
Call1-866-458-2151
Toll Free
Monday through Friday from 9am to 5pm.
Mailto:herbladyisin@yahoo.com
Oasis Serene Refund Policy Below:
Guaranteed Satisfaction with Oasis Serene
We provide a 60 Day No Questions Asked Money Back Guarantee on Oasis Serene.
See privacy statement Full Refund Policy
on all other products :You are welcome to return any of our products (empty bottles or full bottles) at anytime for a full refund. Please don't hesitate to contact us at 1-760-458-2151 Monday to Friday 9:00AM to 5:00 PM Pacific Standard Time.
When you are in the Checkout you will see the padlock for secure ordering in your browser.
herbladyisin@yahoo.com
All information shared with Women's Health is private and secure. We have never sold nor will we ever allow anyone to access this information. The information on this site is not required or has not been evaluated by the Food and Drug Administration. These products are not intended to treat, diagnose, cure, or prevent any disease.
http://www.womenshealth-naturalsolutions.com
Privacy Statement:
Women's Health takes your personal privacy seriously. Because we value our relationship with you, we do not sell customer information or share it with any organization at any time.
-------------------------------------------------------------------------------------------------------
Disclaimer: Extreme Health Oral Chelation Products
All information on this site is provided for informational purposes only! By no means is any information presented herein intended to substitute for the advice provided to you by your own physician or health care provider. You should not use any information contained in our site to self-diagnose or personally treat any medical condition or disease or prescribe any medication. If you have or suspect you have a medical condition you are urged to contact your personal health care provider immediately. All health supplements or products purchased in this site contain clearly labeled product packaging, which must be read to ensure proper use. All information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. It has not been conclusively established that oral chelation is an effective treatment or cure for any disease or condition or that it actually prevents or mitigates such harm. However, Extreme Health, Inc. believes that the use of its products is a responsible precautionary stop for those people who are informed and concerned about such matters.
The National Institute of Health recently began a five-year double blind study on the effects of intravenous chelation. Since qualified doctors have offered their patients chelation treatments for over thirty years, we all look forward to these results. Extreme Health has a doctor's label featuring the exact oral chelation formula that we sell directly to the public. We've sold this to doctors for over four years!
FDA, Pharmaceutical approved manufacturing plant and procedures. Back to the top of the
page
| 
